CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 206 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $357,000 | +28.0% | 13,933 | +18.7% | 0.01% | +40.0% |
| Q2 2022 | $279,000 | +5.7% | 11,742 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $264,000 | +13.3% | 11,742 | -0.2% | 0.00% | 0.0% |
| Q4 2021 | $233,000 | +9.4% | 11,761 | +9.0% | 0.00% | 0.0% |
| Q3 2021 | $213,000 | +6.5% | 10,788 | +18.4% | 0.00% | 0.0% |
| Q2 2021 | $200,000 | -9.5% | 9,109 | -2.0% | 0.00% | -20.0% |
| Q1 2021 | $221,000 | -9.1% | 9,296 | +0.0% | 0.01% | -28.6% |
| Q4 2020 | $243,000 | -52.2% | 9,295 | -68.1% | 0.01% | -53.3% |
| Q3 2020 | $508,000 | +204.2% | 29,120 | +193.5% | 0.02% | +200.0% |
| Q2 2020 | $167,000 | +16600.0% | 9,922 | +10924.4% | 0.01% | – |
| Q4 2019 | $1,000 | -98.6% | 90 | -98.3% | 0.00% | -100.0% |
| Q3 2018 | $74,000 | -86.0% | 5,305 | -84.4% | 0.00% | -81.8% |
| Q2 2018 | $530,000 | -24.9% | 33,922 | -21.0% | 0.01% | -26.7% |
| Q1 2018 | $706,000 | -30.5% | 42,917 | -23.7% | 0.02% | -37.5% |
| Q4 2017 | $1,016,000 | +6.8% | 56,272 | +14.3% | 0.02% | +9.1% |
| Q3 2017 | $951,000 | – | 49,252 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,712,176 | $123,147,000 | 6.01% |
| TANAKA CAPITAL MANAGEMENT INC | 74,139 | $1,048,000 | 3.38% |
| S&T BANK/PA | 625,078 | $8,859,000 | 1.92% |
| Parallel Advisors, LLC | 1,277,851 | $18,062,000 | 1.55% |
| AJ WEALTH STRATEGIES, LLC | 595,828 | $8,422,000 | 1.11% |
| Matarin Capital Management, LLC | 891,636 | $12,603,000 | 0.95% |
| Capital Impact Advisors, LLC | 162,544 | $2,370,000 | 0.90% |
| AMI ASSET MANAGEMENT CORP | 775,685 | $10,964,000 | 0.57% |
| Birchview Capital, LP | 50,000 | $707,000 | 0.47% |
| Zebra Capital Management LLC | 25,409 | $359,000 | 0.39% |